Indapamide
Who holds supplier records for Indapamide? 12 organisations hold a current record for Indapamide: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 11 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: Italy (5), India (2), Spain (1), France (1) and 3 other countries (3).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Indapamide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/indapamide
Reading the evidence
- 12 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 6 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (12)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Indapamide. Country is the organisation's recorded country, not necessarily the manufacturing site.
- BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITEDIndiaCEPActive DMF 38609 · latest filing Jul 2023
- INDUSTRIALE CHIMICA SRLItalyCEP Company GMP cert on recordActive DMF 21663 · latest filing May 2008
- QUIMICA SINTETICA SASpainCEP Company GMP cert on recordActive DMF 9064 · latest filing Mar 1991
- BIOINDUSTRIA LABORATORIO ITALIANO MEDICINALI SPAItaly Company GMP cert on recordActive DMF 9026 · latest filing Mar 1991
- ItalyCEP Company GMP cert on record
- Ipca Laboratories LimitedIndiaCEP Company GMP cert on recordInactive DMF 21975 · latest filing Oct 2008
- ORIL INDUSTRIEFranceCEPInactive DMF 8577 · latest filing May 1990
- GermanyCEP Company GMP cert on record
- Suzhou Lixin Pharmaceutical Co., Ltd.ChinaCEP
- KRKA TOVARNA ZDRAVIL D.D.SloveniaCEPValid CEP holder (EDQM); not necessarily the manufacturer
- BIOINDUSTRIA L.I.M. S.P.A.ItalyCEPValid CEP holder (EDQM); not necessarily the manufacturer
- Laboratori Alchemia SrlItalyCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (11)
Certificates of Suitability on the EDQM register for Indapamide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 13 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED Hyderabad | IN | CEP 2024-143 - Rev 00 Indapamide | Jun 2026 | — |
| KRKA TOVARNA ZDRAVIL D.D. NOVO MESTO Novo mesto | SI | CEP 2024-179 - Rev 00 Indapamide, Micronised | Jun 2025 | Inspected Jul 2025 Slovenia |
| QUIMICA SINTETICA S.A. Alcala De Henares | ES | CEP 2021-159 - Rev 01 Indapamide, Non-micronised, Micronised | Nov 2024 | Inspected Apr 2025 Spain |
| PHARMAZELL GMBH Raubling | DE | CEP 2007-138 - Rev 02 Indapamide | Nov 2023 | Inspected Jun 2025 Germany |
| SUZHOU LIXIN PHARMACEUTICAL CO., LTD. Suzhou | CN | R1-CEP 2012-182 - Rev 01 Indapamide | Feb 2023 | — |
| BIOINDUSTRIA L.I.M. S.P.A. Novi Ligure | IT | R1-CEP 1998-075 - Rev 05 Indapamide | Mar 2022 | — |
| INDUSTRIALE CHIMICA S.R.L. Saronno | IT | R1-CEP 2008-140 - Rev 01 Indapamide | Mar 2021 | — |
| Laboratori Alchemia Srl Milano | IT | R1-CEP 1997-109 - Rev 06 Indapamide, Standard and micronised | Feb 2021 | — |
| ORIL INDUSTRIE Bolbec | FR | R1-CEP 2002-244 - Rev 03 Indapamide | May 2020 | — |
| EDMOND PHARMA S.R.L. Paderno Dugnano | IT | R1-CEP 2004-300 - Rev 04 Indapamide | Jan 2017 | — |
| IPCA Laboratories Limited Mumbai | IN | R1-CEP 2008-268 - Rev 00 Indapamide | Apr 2015 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (2)
Organisations whose Type II DMFs for Indapamide are no longer active. These show a past filing, not current supply.
Show all 2 historical records
- DISHMAN PHARMACEUTICALS AND CHEMICALS LTDInactive DMF 22388 · filed Jan 2009
- South Africa · Inactive DMF 9149 · filed Jun 1991
Overview
Indapamide is a thiazide-like diuretic used primarily to treat hypertension and edema associated with heart failure. It acts by inhibiting the sodium-chloride symporter in the distal convoluted tubule leading to increased excretion of sodium and water.
Chemical identity
- IUPAC name
- 4-chloro-N-(2-methyl-2,3-dihydroindol-1-yl)-3-sulfamoylbenzamide
- Canonical SMILES
- CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
- InChIKey
- NDDAHWYSQHTHNT-UHFFFAOYSA-N
- Synonyms
- Lozol API, arifon, bajaten, br-1015 component indapamide, damide, flubest, fludex, fludin, flupamid, indaflex, indamide, indamol
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Thiazide-like Diuretic
- Physiologic effect
- Increased Diuresis
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Indapamide?
12 organisations hold an active US FDA Type II Drug Master File or a CEP for Indapamide: BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India), INDUSTRIALE CHIMICA SRL (Italy), QUIMICA SINTETICA SA (Spain), BIOINDUSTRIA LABORATORIO ITALIANO MEDICINALI SPA (Italy), EDMOND PHARMA (Italy), Ipca Laboratories Limited (India), ORIL INDUSTRIE (France) and PHARMAZELL GMBH (Germany), and 4 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Indapamide Drug Master Files are active?
BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 38609), INDUSTRIALE CHIMICA SRL (DMF 21663), QUIMICA SINTETICA SA (DMF 9064) and BIOINDUSTRIA LABORATORIO ITALIANO MEDICINALI SPA (DMF 9026). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Indapamide records mean?
2 organisations have only inactive Type II DMFs for Indapamide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Indapamide have a European Certificate of Suitability?
Yes. 11 organisations hold a valid CEP for Indapamide on the EDQM register, including BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED Hyderabad (IN), KRKA TOVARNA ZDRAVIL D.D. NOVO MESTO Novo mesto (SI), QUIMICA SINTETICA S.A. Alcala De Henares (ES), PHARMAZELL GMBH Raubling (DE), SUZHOU LIXIN PHARMACEUTICAL CO., LTD. Suzhou (CN) and BIOINDUSTRIA L.I.M. S.P.A. Novi Ligure (IT) and 5 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Indapamide supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Indapamide?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.